About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Multiple Sclerosis Drug Brakes Progression to Full-Blown Disease

by VR Sreeraman on October 7, 2009 at 6:09 PM
Font : A-A+

 Multiple Sclerosis Drug Brakes Progression to Full-Blown Disease

Early treatment with a key drug to fight multiple sclerosis (MS) nearly halves the risk of progression to the full-blown disease, according to a study published online on Wednesday by The Lancet.

The treatment, glatiramer acetate, marketed as Copaxone, was tested in 16 countries among 481 patients with a tell-tale lesion in the central nervous system called clinically isolated syndrome.

Advertisement

The volunteers either received the drug or a dummy lookalike for up to three years.

Copaxone reduced the risk of developing "clinically definite" MS by 45 percent compared with a placebo.

In addition, the time it took for 25 percent of patients to develop the full-scale disease was more than doubled in the Copaxone group, at just under two years on average compared with just under one year in the placebo group.
Advertisement

Around a million people around the world are affected by MS, a degenerative disease in which the immune system attacks myeline, the fatty sheath that protects nerve fibres.

As a result, signals between nerve cells are delayed, disrupted or even blocked, rather like a poor connection in an electrical wire.

This causes worsening problems in coordination and balance, as well as blurred vision and slurred speech.

"This study establishes glatiramer acetate as an option for patients with clinically isolated syndrome who choose to start treatment early to improve control of the underlying disease process," says the new paper.

The study was led by Giancarlo Comi, a professor of neurology at Milan's Vita-Salute University in Italy.

Copaxone is currently approved for treating "relapsing-remitting" forms of MS.

Source: AFP
SRM
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Top 9 Reasons Why We Should Practice Kindness
Top 10 Vitamin B12 Foods for Vegetarians - Slideshow
Targeted Screening Program Beneficial for Prostate Cancer Screening
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Chemotherapy Chemotherapy Drugs Signature Drug Toxicity Infectious Mononucleosis Multiple Sclerosis Treatment and Modify Optic Neuritis Autoimmune Disorders Health Risks of Eating Pork 

Most Popular on Medindia

Indian Medical Journals Find a Doctor Calculate Ideal Weight for Infants Noscaphene (Noscapine) Sinopril (2mg) (Lacidipine) Drug - Food Interactions How to Reduce School Bag Weight - Simple Tips Drug Interaction Checker Find a Hospital Blood Pressure Calculator

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use